'I get to continue watching my children grow up': Cork cancer trial to provide more personalised treatment

Melody trial will use routine blood tests to identify the genetic characteristics of advanced breast cancers, helping doctors tailor treatments
Breakthrough Cancer Research CEO Orla Dolan, UCC professor Roisin Connolly, and Dr Emer Lynch, Breakthrough Clinical Cancer Research Fellow at UCC, at the launch of the Melody trial at CUH. Picture: Daragh Mc Sweeney/Provision

Breakthrough Cancer Research CEO Orla Dolan, UCC professor Roisin Connolly, and Dr Emer Lynch, Breakthrough Clinical Cancer Research Fellow at UCC, at the launch of the Melody trial at CUH. Picture: Daragh Mc Sweeney/Provision

A woman who underwent brain surgery after breast cancer spread to her brain has welcomed a new cancer trial in Cork, saying she hopes it will help other patients avoid some of the uncertainty she faced.

The trial opens in October and will run for an initial two years with patients at Cork University Hospital. 

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited